Cardinal Health Inc. has announced the acquisition of Solaris Health, further advancing its multi-specialty growth strategy. The transaction, expected to close by the end of 2025, will see Cardinal Health owning approximately 75% of The Specialty Alliance. The acquisition will be financed through a combination of cash on hand and new debt financing. Cardinal Health plans to integrate Solaris Health into The Specialty Alliance, enhancing its reach within the Urology Alliance. The deal is anticipated to be slightly accretive to non-GAAP earnings per share within the first year following completion. Financial and legal advisory support for the transaction was provided by Goldman Sachs, Skadden, Arps, Slate, Meagher & Flom LLP, and Katten Muchin Rosenman LLP, with Centerview Partners and McDermott, Will & Emery advising Solaris Health.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。